Advances in Hematology

Aggressive B-Cell Lymphomas


Publishing date
15 Apr 2012
Status
Published
Submission deadline
15 Oct 2011

1Department of Histopathology, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0HS, UK

2International Network for Cancer Treatment and Research, Rue Engeland 642, 1180 Brussels, Belgium

3Service d'Hématologie et Immunologie Biologiques, Cytogénétique, Traitement de l'Hémophilie et Thérapie Transfusionnelle, CHU Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex, France

4Department of Human Pathology and Oncology, University of Siena, Siena, Italy


Aggressive B-Cell Lymphomas

Description

Aggressive B-cell lymphomas (ABL) as group of B-cell malignancies are relevant across the world—both in the developing and the developed world. There are significant differences in the incidence/prevalence of ABLs across the world. A significant proportion of them are associated with infective agents, and associations with specific genetic abnormalities are expanding. Precise classification of some of these entities has been difficult and “grey” zones between different entities are well accepted. The role of gene expression and microRNA expression in defining disease biology has generated wide interest. Apart from tumour-related attributes, the microenvironment in these diseases play a major role in disease biology. Furthermore, appropriate management of these patients to achieve cure has been challenging. To achieve this in the background of different geographic and economic settings adds yet another dimension.

We are particularly interested in compiling manuscripts that address the above issues in various ABLs. Potential topics include, but are not limited to:

  • Epidemiology
  • Association with infective agents
  • Genetic abnormalities and epigenetic alterations
  • Issues related to disease classification
  • Gene and microRNA expression
  • Microenvironment
  • Disease management
  • Biomarkers of the following diseases:
    • B-lymphoblastic lymphoma
    • Mantle cell lymphoma
    • Burkitt's lymphoma
    • Diffuse large B-cell lymphoma
    • Other large B-cell lymphomas
    • Lymphomas in immune deficiency states
    • Grey zone lymphomas

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ah/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 604603
  • - Editorial

Aggressive B-Cell Lymphomas

Kikkeri N. Naresh | Ian Magrath | ... | Lorenzo Leoncini
  • Special Issue
  • - Volume 2012
  • - Article ID 149780
  • - Research Article

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma

Susanna Mannucci | Anna Luzzi | ... | Giulia De Falco
  • Special Issue
  • - Volume 2012
  • - Article ID 230173
  • - Review Article

Posttransplant Lymphoproliferative Disorders

Hazem A. H. Ibrahim | Kikkeri N. Naresh
  • Special Issue
  • - Volume 2012
  • - Article ID 494758
  • - Review Article

A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal

Corry van den Bosch
  • Special Issue
  • - Volume 2012
  • - Article ID 460801
  • - Review Article

Grey Zone Lymphomas: Lymphomas with Intermediate Features

Sylvia Hoeller | Christiane Copie-Bergman
  • Special Issue
  • - Volume 2012
  • - Article ID 302570
  • - Review Article

Novel Therapies for Aggressive B-Cell Lymphoma

Kenneth A. Foon | Kenichi Takeshita | Pier L. Zinzani
  • Special Issue
  • - Volume 2012
  • - Article ID 529572
  • - Review Article

Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma

Elizabeth A. Morgan | Alessandra F. Nascimento
  • Special Issue
  • - Volume 2012
  • - Article ID 138079
  • - Review Article

Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas

Matilde Cacciatore | Carla Guarnotta | ... | Claudio Tripodo
  • Special Issue
  • - Volume 2012
  • - Article ID 701704
  • - Review Article

Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies

Sabrina Donnou | Claire Galand | ... | Sylvain Fisson
  • Special Issue
  • - Volume 2012
  • - Article ID 485943
  • - Review Article

AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy

Prakash Vishnu | David M. Aboulafia
Advances in Hematology
 Journal metrics
Acceptance rate8%
Submission to final decision77 days
Acceptance to publication25 days
CiteScore3.800
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.